Newman Dignan & Sheerar, Inc. - Q2 2014 holdings

$175 Million is the total value of Newman Dignan & Sheerar, Inc.'s 143 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 100.0% .

 Value Shares↓ Weighting
GIM ExitTempleton Global Income Fd$0-25,730
-100.0%
-0.15%
ESRX ExitExpress Scripts Inc$0-3,019
-100.0%
-0.16%
SYY ExitSysco Inc$0-6,776
-100.0%
-0.17%
RTN ExitRaytheon Corp Cl B$0-3,150
-100.0%
-0.22%
CL ExitColgate Palmolive Co$0-5,280
-100.0%
-0.24%
ADI ExitAnalog Devices Inc$0-6,650
-100.0%
-0.25%
BIDU ExitBaidu Com Inc Adradr$0-2,602
-100.0%
-0.28%
HSBCPRA ExitH S B C Hldgs 6.2% Pfdpfd$0-22,500
-100.0%
-0.41%
RSP ExitGuggenheim S&P 500 Eq. Wgt.etf$0-11,580
-100.0%
-0.60%
PBE ExitBiotech/Genome Powershares Indetf$0-31,525
-100.0%
-0.93%
DGS ExitWisdomtree Emerg Mkts SmCap Dietf$0-32,590
-100.0%
-1.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-07-22
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Schwab Dow Jones US Div Eq ETF42Q3 20236.6%
Schwab Dow Jones US Large Cap ETF42Q3 20237.3%
Schwab Dow Jones US Large Growth ETF42Q3 20234.9%
Schwab Dow Jones US Large Value ETF42Q3 20234.5%
Apple, Inc42Q3 202320.8%
Schwab Dow Jones US Sm-Cap ETF42Q3 202313.5%
Microsoft Corp42Q3 20233.4%
Johnson & Johnson42Q3 20232.9%
Novartis A G42Q3 202356.8%
Merck & Co Inc42Q3 20232.5%

View Newman Dignan & Sheerar, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-02-09
13F-HR2023-11-08
13F-HR2023-08-02
13F-HR2023-04-28
13F-HR2023-01-20
13F-HR2022-10-18
13F-HR2022-08-03
13F-HR2022-04-14
13F-HR2022-01-18

View Newman Dignan & Sheerar, Inc.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (175364000.0 != 175634000.0)

Export Newman Dignan & Sheerar, Inc.'s holdings